Compare IDEXX Laboratories, Inc. (IDXX) vs M&T Bank Corporation (MTB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
IDEXX Laboratories, Inc. vs M&T Bank Corporation — how do they compare? IDEXX Laboratories, Inc. trades at $552.09 (market cap $44.48B), while M&T Bank Corporation trades at $247.94 (market cap $36.15B). The key difference: IDEXX Laboratories, Inc. is the larger of the two by market cap, and M&T Bank Corporation pays a 2.41% dividend while IDEXX Laboratories, Inc. pays none. Which is the better fit depends on your goals.
| IDXX | MTB | |
|---|---|---|
Market Cap | $44.48B | $36.15B |
Sector | Health | Financials |
52-Week High | $766.68 | $254.04 |
52-Week Low | $520.87 | $178.63 |
Enterprise Value | $45.38B | — |
Dividend Yield | — | 2.41% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IDXX trades at $563.79, down 0.64% today but maintains strong fundamental momentum with consistent earnings beats and robust profitability. The stock shows bullish technical signals with support at $563 and resistance at $572, while valuation metrics remain elevated. Recent Q1 2026 results exceeded expectations with EPS of $3.47 versus $3.41 estimates, supporting the company's leadership in veterinary diagnostics.
Outlook remains positive given strong analyst support (59% buy ratings) and innovation pipeline, though premium valuations and competitive pressures present risks. Revenue growth trajectory and expanding margins provide fundamental support for continued upside potential in the pet healthcare sector.
M&T Bank (MTB) trades at $249.54, up 0.12% on the day, with a bullish technical signal and consistent earnings beats in recent quarters. The stock shows strong fundamentals with a P/E of 13.19 and net income margin of 30.85%, supported by robust loan growth and net interest income as highlighted in Q2 2026 results. Analyst consensus is a buy with a $253.68 price target, though the majority of ratings are hold.
The outlook for MTB is positive due to solid earnings performance and healthy credit quality, but risks include elevated costs and macroeconomic pressures. Investment opportunity lies in its valuation and dividend yield, while investors should monitor expense management and interest rate sensitivity.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →About M&T Bank Corporation
M&T Bank is one of the largest regional banks in the United States, with branches in New York, Pennsylvania, West Virginia, Virginia, Maryland, Delaware, and New Jersey. The bank was founded to serve manufacturing and trading businesses around the Erie Canal and is primarily focused on commercial real estate and commercial-related lending, with some retail operations also present.
Read more on MTB →
